AIM ImmunoTech Announces Addition of Single-Agent Ampligen Arm to Cancer Center's Ongoing Study in Cancer Patients with COVID-19

AIM ImmunoTech Announces Addition of Single-Agent Ampligen Arm to Cancer Center's Ongoing Study in Cancer Patients with COVID-19 

OCALA, Fla., March 22, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that the Institutional Review Board (IRB) of Roswell Park Comprehensive Cancer Center (Roswell Park) has approved a protocol amendment to Roswell Park's ongoing Phase 1/2a study evaluating the two-drug combination of AIM's Ampligen and interferon alpha-2b as a potential early-onset treatment for patients with cancer and mild-to-moderate COVID-19. The IRB-approved amendment calls for randomization of an additional twenty patients. Ten of these patients will receive a single dose of Ampligen, but no interferon treatment, and the other ten will receive best available care only. Ampligen alone has a generally well-tolerated safety profile with lower risk of adverse events than is generally expected with interferon therapy. "We are excited to see Ampligen tested not only as part of an antiviral treatment combination for COVID-19 among cancer patients, but also as a possible standalone therapy for this terrible virus," said AIM CEO Thomas K. Equels. "An early-onset treatment is especially critical for cancer patients, who face significantly increased risk of severe symptoms or death."


https://aimimmuno.irpass.com/ViewEmail.asp?b=2265&id=200459&p=2190717&I=1243298-K2r3p5x9n5


Popular Posts in the Last 7 Days

Is there, in all likelihood, an undetected epidemic of *internal* Kaposi's sarcoma in Chronic Fatigue Syndrome patients?

What is the role of HHV-6 in Kaposi's Sarcoma?

Important and provocative books about HHV-6 and the epidemics it may be causing available from Amazon in print editions or on Kindle:

"HHV-6A, but not B, also replicates in various cytotoxic effector cells, such as CD8+ T cells, gammadelta T cells and natural killer cells."

Bulletin #8 from the Coordinating Committee of The International HHV-6 Protest and Teach-in At Harvard (November 9-11, 2015)

John Beldekas and HHV-6

HHV-8 and KS in CFIDS

African Swine Fever and Kaposi's Sarcoma

The Price of CDC/NIH/Fauci's HHV-6 Indifference

Popular Post in the Last 30 Days

From Perplexity: Here are 20 ways the pharmaceutical industry should reorient their AIDS efforts based on Rebecca Culshaw’s Substack critique of the HIV paradigm:

Memo to CFS patients and CFS quacks: Let's get something straight.

A Perplexity conversation about self-deceit, conspiracy, Arendt and AIDS

Groq on Hannah Arendt and science

Perplexity on AIDS paradigm shift in nosology and funding

Perplexity on K.S. and AIDS and inflammation

Perplexity on the AIDS paradigm

Perplexity names the AIDS Paradigm 20

How Kaposi's Sarcoma almost undermined the HIV theory of AIDS

Popular Posts from the Last Year

Perplexity on Rebecca Culshaw Smith, and PrEP as Genocide

Why Brigitte Huber may be the most important AIDS and Chronic Fatigue Syndrome researcher

From Perplexity A.I.: A major nosological mistake in AIDS—meaning a fundamental error in how the disease is defined, classified, or diagnosed—could be the most consequential nosological error in history because of several deeply impactful social, scientific, and ethical consequences.

Perplexity on the issue of endogenous versus exogenous retroviruses. Is this a key to the HIV mistake?

Perplexity on K.S. and AIDS and inflammation

Oral Kaposi's Sarcoma looks like the Crimson Crescents in Chronic Fatigue Syndrome patients.

How Kaposi's Sarcoma almost undermined the HIV theory of AIDS

All Time Most Popular Posts

Dr. Bhupesh Prusty and Professor Thomas Rudel discuss their HHV-6 research

Anthony Fauci was part of the gang that silenced and destroyed Judy Mikovits.

Was Judy Mikovits destroyed because her XMRV work would have ultimately shown HIV is a total fraud?

Is Chronic Fatigue Syndrome the other AIDS epidemic in the gay community?